Seung-Taek Lee

EmailSTLEEYONSEI.ACKR

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Seung-Taek Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

113 Article
1 Letter

Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma
Kim, J. H., Shin, W. S., Lee, S. R., Kim, S., Choi, S. Y. & Lee, S. T., 2022 Oct, In: International journal of molecular sciences. 23, 20, 12195.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Citation (Scopus)
Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
Oh, S. W., Shin, W. S. & Lee, S. T., 2022 Sept, In: Cancers. 14, 18, 4463.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
Expression of Polyamine Oxidase in Fibroblasts Induces MMP-1 and Decreases the Integrity of Extracellular Matrix
Jeong, H. D., Kim, J. H., Kwon, G. E. & Lee, S. T., 2022 Sept, In: International journal of molecular sciences. 23, 18, 10487.
Research output: Contribution to journal › Article › peer-review

Open Access
Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
Kim, J. H. & Lee, S. T., 2022 Jul 1, In: International journal of molecular sciences. 23, 14, 7521.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Citation (Scopus)
PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells
Shin, W. S., Park, M. K., Kim, J. H., Oh, S. W., Jang, J. Y., Lee, H. & Lee, S. T., 2022 Feb 1, In: International journal of molecular sciences. 23, 4, 2391.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Citations (Scopus)

Researchers at Yonsei University Release New Study Findings on Xenografts (Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma)
Seung-Taek Lee
22/11/8
1 item of Media coverage
Press/Media: Press / Media

Seung-Taek Lee

Fingerprint

Network

Dive into details

Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma

Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function

Expression of Polyamine Oxidase in Fibroblasts Induces MMP-1 and Decreases the Integrity of Extracellular Matrix

Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells

PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells

Researchers at Yonsei University Release New Study Findings on Xenografts (Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma)

Seung-Taek Lee

Fingerprint

Network

Research output

Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma

Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function

Expression of Polyamine Oxidase in Fibroblasts Induces MMP-1 and Decreases the Integrity of Extracellular Matrix

Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells

PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells

Press/Media

Researchers at Yonsei University Release New Study Findings on Xenografts (Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma)